Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
出版年份 2020 全文链接
标题
Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
作者
关键词
-
出版物
Cancers
Volume 12, Issue 8, Pages 2228
出版商
MDPI AG
发表日期
2020-08-10
DOI
10.3390/cancers12082228
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- TERT, BRAF, and NRAS mutational heterogeneity between paired primary and metastatic melanoma tumors
- (2020) Gregory A. Chang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pre‐analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients
- (2020) Svenja Schneegans et al. Molecular Oncology
- Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies
- (2019) Ashleigh C. McEvoy et al. Oncotarget
- Genomic Analysis of Circulating Tumor DNA Using a Melanoma-Specific UltraSEEK Oncogene Panel
- (2019) Elin S. Gray et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA
- (2019) L Tan et al. ANNALS OF ONCOLOGY
- Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients
- (2019) J H Lee et al. ANNALS OF ONCOLOGY
- The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma
- (2019) Bengt Phung et al. Cell Reports
- Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy
- (2019) Teofila Seremet et al. Journal of Translational Medicine
- Technical progress in circulating tumor DNA analysis using next generation sequencing
- (2019) Yunfei Bai et al. MOLECULAR AND CELLULAR PROBES
- Blood‐Based Next‐Generation Sequencing Analysis of Appendiceal Cancers
- (2019) Walid L. Shaib et al. ONCOLOGIST
- Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients
- (2019) Katharina Gorges et al. Cancers
- Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma
- (2019) Russell J. Diefenbach et al. Cancers
- Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway
- (2019) Sisi Chen et al. Nature Communications
- Circulating Tumor DNA: Measurement and Clinical Utility
- (2018) Joshua Donaldson et al. Annual Review of Medicine
- Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
- (2018) Ashleigh C. McEvoy et al. BMC CANCER
- Comprehensive Characterization of Cancer Driver Genes and Mutations
- (2018) Matthew H. Bailey et al. CELL
- Optimizing Amplification of the GC-RichTERTPromoter Region Using 7-Deaza-dGTP for Droplet Digital PCR Quantification ofTERTPromoter Mutations
- (2018) Andrew J. Colebatch et al. CLINICAL CHEMISTRY
- Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients
- (2018) S. Valpione et al. EUROPEAN JOURNAL OF CANCER
- Untargeted profiling of cell-free circulating DNA
- (2018) Qing Zhou et al. Translational Cancer Research
- Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies
- (2018) Jenny H. Lee et al. JAMA Oncology
- Circulating tumor DNA – Current state of play and future perspectives
- (2018) Gabriele De Rubis et al. PHARMACOLOGICAL RESEARCH
- Monitoring Melanoma Using Circulating Free DNA
- (2018) Russell J. Diefenbach et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis
- (2018) Anna M. Rose et al. BMC CANCER
- Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma Samples
- (2018) Broderick Corless et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma
- (2018) Leslie Calapre et al. Molecular Oncology
- The feasibility of using mutation detection in ctDNA to assess tumor dynamics
- (2017) Xin Yi et al. INTERNATIONAL JOURNAL OF CANCER
- Whole-genome landscapes of major melanoma subtypes
- (2017) Nicholas K. Hayward et al. NATURE
- Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma
- (2017) Ashleigh C. McEvoy et al. Oncotarget
- BRAFV600EandNRASQ61L/Q61Rmutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting
- (2016) Hojabr Kakavand et al. HISTOPATHOLOGY
- TERTpromoter mutations in melanoma survival
- (2016) Eduardo Nagore et al. INTERNATIONAL JOURNAL OF CANCER
- EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center
- (2016) Riccardo Giannini et al. ONCOLOGY REPORTS
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials
- (2015) A. Santiago-Walker et al. CLINICAL CANCER RESEARCH
- Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique
- (2015) Mark Kriegsmann et al. Diagnostic Pathology
- Recurrent inactivating RASA2 mutations in melanoma
- (2015) Rand Arafeh et al. NATURE GENETICS
- Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
- (2015) Elin S. Gray et al. Oncotarget
- Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma
- (2014) Kristina Warton et al. BMC GENOMICS
- Quantitative Cell-Free Circulating BRAFV600E Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with BRAF Inhibitors
- (2014) M. F. Sanmamed et al. CLINICAL CHEMISTRY
- Age-related mutations associated with clonal hematopoietic expansion and malignancies
- (2014) Mingchao Xie et al. NATURE MEDICINE
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma
- (2014) Barbara Heidenreich et al. Nature Communications
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More